CysBio (private company)
See something wrong or missing? Let us know
Offices:
Copenhagen
Category:
Biotech Health services
Business model:
B2B
Investors:
Zhejiang NHU
Total investments received (USD) - 6.21M
- Mar 2019 -
6.21M
Cysbio uses advanced metabolic engineering and synthetic biology approaches to construct bacterial cell factories for transforming the production of biochemicals from renewable feedstocks.
Cysbio is a spin-out from the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark.